[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604233":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":60,"collaborators":10,"id":62,"slug":10,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":10,"eligibilityCriteria":66,"healthyVolunteers":63,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Phraxis, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"EndoForce",null,"AV Graft implanted using the EndoForce Connector for Endovascular Venous Anastomosis",[13],{"name":14,"affiliation":15,"role":16},"Ari Kramer, MD","Spartanburg Regional Medical Center","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"John Zentgraf","CONTACT","651-260-6673","jzentgraf@phraxis.com",[24,45],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"MUSC Health Orangeburg","NOT_YET_RECRUITING","Orangeburg","South Carolina","29118","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-80.85565,33.49182,{"lat":36,"lon":35},[39,43],{"name":40,"role":20,"phone":41,"phoneExt":10,"email":42},"Virginia Anderson","803-395-3878","andersvi@musc.edu",{"name":44,"role":16,"phone":10,"phoneExt":10,"email":10},"Mark London, MD",{"facility":15,"status":46,"city":47,"state":28,"zip":48,"country":30,"countryCode":31,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"RECRUITING","Spartanburg","29303",{"type":33,"coordinates":50},[51,52],-81.93205,34.94957,{"lat":52,"lon":51},[55,59],{"name":56,"role":20,"phone":57,"phoneExt":10,"email":58},"Darla Howard","864-590-5521","DHoward@srhs.com",{"name":14,"role":16,"phone":10,"phoneExt":10,"email":10},{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100604233",false,"NCT07146854","EndoForce Post Approval Study","Inclusion Criteria:\n\n* Patient is ≥18 years of age.\n* Patient requires the creation of a vascular access graft for hemodialysis, secondary to a diagnosis of ESRD.\n* Patient is able to have the vascular access ePTFE graft placed in an upper arm.\n* Patient or his\u002Fher legal guardian understands the study and is willing and able to comply with the dialysis schedule and follow-up requirements.\n* Patient or his\u002Fher legal guardian provides written informed consent.\n\nExclusion Criteria:\n\n* All contraindications for the EndoForce Connector System according to the IFU.\n* Patient is pregnant.\n* Patient is enrolled in another dialysis or vascular investigational study, without prior approval from the Sponsor.","ALL","18 Years",{"count":70,"type":71},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.",[75],"End Stage Renal Disease (ESRD)",[77,78],"Hemodialysis","Arteriovenous graft","2026-01-16",{"date":81,"type":82},"2026-01-21","ACTUAL",{"date":84,"type":82},"2026-01-13",{"date":86,"type":71},"2029-12",{"name":5,"class":6},2]